Triglyceride lowering 2.0: back to the future?
Author:
Affiliation:
1. Institute of Cardiovascular and Medical Sciences, University of Glasgow, Glasgow, UK
Publisher
Oxford University Press (OUP)
Subject
Cardiology and Cardiovascular Medicine
Link
http://academic.oup.com/eurheartj/advance-article-pdf/doi/10.1093/eurheartj/ehz810/30701013/ehz810.pdf
Reference15 articles.
1. The selective peroxisome proliferator-activated receptor alpha modulator (SPPARMα) paradigm: conceptual framework and therapeutic potential: a consensus statement from the International Atherosclerosis Society (IAS) and the Residual Risk Reduction Initiative (R3i) Foundation;Fruchart;Cardiovasc Diabetol,2019
2. 2019 ESC/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk;Mach;Eur Heart J,2019
3. Increasing lipolysis and reducing atherosclerosis;Tall;N Engl J Med,2017
4. Triglyceride-rich lipoproteins and atherosclerotic cardiovascular disease: new insights from epidemiology, genetics, and biology;Nordestgaard;Circ Res,2016
5. Lipoprotein heterogeneity and apolipoprotein B metabolism;Packard;Arterioscler Thromb Vasc Biol,1997
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Evaluation of Plasma Atherogenic Index, Triglyceride-Glucose Index and Other Lipid Ratios as Predictive Biomarkers of Coronary Artery Disease in Different Age Groups;Diagnostics;2024-07-11
2. Impact of diabetes mellitus and triglyceride glucose index on mortality and cardiovascular outcomes in patients with chronic coronary syndrome undergoing coronary computed tomography angiography;International Journal of Cardiology Cardiovascular Risk and Prevention;2024-03
3. Remnant cholesterol, but not low‐density lipoprotein cholesterol, is associated with intra‐pancreatic fat deposition;Diabetes, Obesity and Metabolism;2023-08-02
4. Targeting angiopoietin‐like 3 in atherosclerosis: From bench to bedside;Diabetes, Obesity and Metabolism;2021-06-17
5. Targeting RNA With Antisense Oligonucleotides and Small Interfering RNA in Dyslipidemias;Journal of the American College of Cardiology;2020-08
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3